Physician profile
Meredith A Warner
NPI 1467516567
$231,747.85
in general payments reported to CMS, 2019-2025
35 companies · $65K in 2025
The $65K reported for 2025 was more than what 92% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $9,423 · 2020: $6,642 · 2021: $26K · 2022: $26K · 2023: $32K · 2024: $66K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $131K · Travel and Lodging: $19K · Royalty Or License: $8,716 · Food and Beverage: $3,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,053.26 |
| Travel and Lodging | $19,195.06 |
| Royalty Or License | $8,716.00 |
| Food and Beverage | $3,972.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $134,174.37 | 2019-2025 | Truelok, Galaxy Fixation System, Ankle Hindfoot Nailing System |
| Extremity Medical | $32,171.68 | 2020-2025 | Axis |
| Novastep INC. | $18,145.12 | 2020-2022 | |
| Bonalive INC | $16,609.74 | 2025 | |
| Bioventus LLC | $13,606.00 | 2020-2025 | Stimrouter Implantable Kit |
| Arthrex, INC. | $4,886.63 | 2019 | |
| Alon Medical Technology | $2,877.46 | 2019-2025 | |
| Biopro, INC. | $2,000.00 | 2025 | Hemi Toe |
| Medshape, INC. | $1,697.18 | 2025 | |
| Organogenesis INC. | $1,358.02 | 2020-2023 | Puraply |
| Wright Medical Technology, INC. | $892.10 | 2019 | |
| Stryker Corporation | $854.82 | 2019-2025 | Inbone, N/A, Salvation |
| Horizon Therapeutics Plc | $464.35 | 2019-2022 | |
| Ortho Solutions INC | $361.41 | 2019-2020 | |
| Medtronic, INC. | $250.96 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $230.01 | 2020 | |
| Acera Surgical, INC. | $217.17 | 2025 | Restrata Wound Matrix |
| Flower Orthopedics Coporation | $124.81 | 2021 | |
| Biocomposites INC | $112.56 | 2024 | |
| Novo Nordisk INC | $106.65 | 2022 | |
| Zimmer Biomet Holdings, INC. | $104.20 | 2020-2021 | |
| Depuy Synthes Sales INC. | $78.90 | 2019-2025 | Monovisc |
| Pfizer INC. | $75.85 | 2020-2021 | |
| Smith+Nephew, INC. | $69.75 | 2019 | |
| Medline Industries LP | $58.07 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $47.65 | 2020-2025 | Exparel, Iovera, Zilretta |
| Merz North America, INC. | $39.53 | 2019 | |
| Nevro Corp. | $26.10 | 2022 | |
| Globus Medical, INC. | $23.82 | 2025 | Anthem |
| Vertex Pharmaceuticals Incorporated | $19.88 | 2025 | |
| Kci USA, INC. | $19.79 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2023 | Seglentis |
| Checkpoint Surgical, INC | $11.83 | 2025 | Checkpoint Stimulators |
| Apria Healthcare LLC | $11.67 | 2021 | |
| Fidia Pharma USA INC. | $4.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$46,737.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.